{"nct_id":"NCT03154086","title":"A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers","status":"COMPLETED","status_verified_date":"2019-06","start_date":"2017-05-17","start_date_type":"ACTUAL","primary_completion_date":"2018-03-05","primary_completion_date_type":"ACTUAL","completion_date":"2018-03-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}